Photo of Lori Trahan
D United States House · District 3 · Massachusetts On the 2026 ballot

Rep. Lori Trahan

Compare
Total votes
2,837
all sessions
Attendance
98%
47 missed
Lower than 76% of chamber peers
With party
98%
of cast votes
Higher than 77% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 78% of chamber peers
Sponsored
1,258
bills & resolutions
Near the chamber average
Committees
4
assignments
1,258 bills and resolutions

Sponsored bills

Total
1,258
Primary
51
Co-sponsor
1,207
This page
1,258
matching current filters
Co-sponsor HR 4543
In committee · Indiana House · Co-sponsor
Medicaid Breast Cancer Access to Treatment Act

Maddy summaryThis bill requires Medicaid programs to cover specific treatments for individuals with breast or cervical cancer. It adds a new provision to Medicaid rules that explicitly includes these patients in mandatory coverage, ensuring states must provide necessary care. The bill also mandates that Medicaid cover breast reconstruction surgery following a medically necessary mastectomy. These changes directly affect Medicaid beneficiaries diagnosed with breast or cervical cancer who need these specific treatments. The policy update removes gaps in existing coverage for these critical cancer care services.

In committee Jul 17, 2025 1 co-sponsor
Co-sponsor HR 4545
In committee · Indiana House · Co-sponsor
Medicare Breast Reconstruction Access and Information Act

Maddy summaryHR 4545, the Medicare Breast Reconstruction Access and Information Act, requires healthcare providers to inform Medicare patients about coverage for breast reconstruction surgery before performing a mastectomy. The bill amends the Social Security Act to mandate that suppliers providing a mastectomy must explain that reconstruction is covered under Medicare's national coverage determination 140.2 and document this discussion in the patient's medical record. This applies specifically to Medicare beneficiaries undergoing medically necessary mastectomies. The law ensures patients receive clear information about existing coverage options prior to surgery, without changing Medicare's benefit structure.

In committee Jul 17, 2025 1 co-sponsor
Co-sponsor HR 4525
In committee · Indiana House · Co-sponsor
Right to FDA-Approved Medicines Act

Maddy summaryThis bill prohibits federal and state governments from restricting access to FDA-approved medicines. It guarantees individuals the right to obtain these medicines without coercion and allows healthcare providers (like doctors and pharmacists) to prescribe or refer for them. The law blocks governments from implementing rules that single out or hinder the sale, provision, or use of FDA-approved drugs, such as bans on specific medicines or barriers to patient access. It does not affect the FDA's drug approval process or existing health insurance coverage requirements.

In committee Jul 17, 2025 1 co-sponsor
Co-sponsor HCONRES 44
In committee · Indiana House · Co-sponsor
Recognizing a health and safety emergency disproportionately affecting the fundamental rights of children due to the Trump administration's directives that unleash fossil fuels and greenhouse gas emissions that contribute to climate change, while suppressing climate change science.

Maddy summaryHCONRES 44 is a symbolic resolution recognizing a health and safety emergency for children linked to the Trump administration's climate policies. It claims these policies - unleashing fossil fuel production, blocking renewable energy, and suppressing climate science - disproportionately harm children through increased air pollution, extreme weather, and denied access to climate data. The resolution calls for reversing these policies, restoring the EPA's mission, and ensuring climate action aligns with protecting children's rights. It does not enact new laws or change policy, but serves as a formal congressional statement of concern.

In committee Jul 16, 2025 1 co-sponsor
Co-sponsor HR 4445
In committee · Indiana House · Co-sponsor
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025

Maddy summaryThis bill extends the Public Health and Bio-Preparedness Workforce Loan Repayment Program through fiscal years 2026 to 2030, replacing the previous 2023-2025 funding period. It directly affects public health workers (such as epidemiologists, laboratory staff, and emergency response personnel) who have federal student loans. The key provision reauthorizes existing funding to help these workers repay student debt by providing federal reimbursements. This maintains a critical workforce retention tool for agencies like the CDC and state health departments without creating new benefits or altering eligibility. The change is procedural, solely adjusting the program's funding timeline.

In committee Jul 16, 2025 1 co-sponsor
Co-sponsor HR 4393
In committee · Indiana House · Co-sponsor
DIGNIDAD (Dignity) Act of 2025

Maddy summary# Summary of "Dignity for Immigrants while Guarding our Nation to Ignite and Deliver the American Dream Act" This comprehensive immigration bill proposes multiple pathways to legal status and permanent residency for undocumented immigrants while creating new employment and workforce development programs. ## Key Provisions: 1. **Dignity Program (Subtitle III)**: - Creates a 7-year program for eligible undocumented immigrants requiring $7,000 in restitution payments to an H-1B fund - Provides deferred action on removal, work authorization, and travel privileges - Requires participants to maintain employment/education, pay taxes, and comply with all laws - Upon completion, participants receive "Dignity Status" valid for 7 years with renewal options 2. **Workforce Development (Division C)**: - Directs restitution payments to fund apprenticeships and work-based learning programs - Establishes industry partnerships to support small- and medium-sized businesses - Focuses on "in-demand industry sectors" with targeted training programs - Requires 12 months of post-employment support services for participants 3. **Family Reunification (Section 3111-3115)**: - Expands discretionary authority for family-based relief - Creates new "family purpose" nonimmigrant visa category (90-day limit) - Modernizes military naturalization for service members - Includes protections for children affected by visa backlogs 4. **Backlog Reduction (Section 3201-3203)**: - Creates premium processing for long-pending cases ($20,000 fee) - Increases per-country caps from 7% to 15% - Protects children from "aging out" of family-based visas 5. **Student and Worker Visas (Section 3301-3305)**: - Modernizes student visa categories with "dual intent" provisions - Recognizes doctoral STEM graduates as "extraordinary ability" - Streamlines visa processing through a new Immigration Agency Coordinator The bill aims to balance immigration reform with workforce development, creating a pathway to legal status while directing funds toward American workers through apprenticeships and training programs in high-demand fields.

In committee Jul 16, 2025 1 co-sponsor
Primary HR 1442
Passed · Indiana House · Lead sponsor
To ban the sale of products with a high concentration of sodium nitrite to individuals, and for other purposes.

Maddy summaryHR 1442, the Youth Poisoning Protection Act, bans consumer products containing 10% or more sodium nitrite by classifying them as hazardous under existing safety laws. This directly affects manufacturers and sellers of such products, including certain food coloring or preservation items. The ban excludes industrial uses, drugs, cosmetics, and food products like poultry, meat, and eggs under federal food safety definitions. It takes effect 90 days after enactment, targeting products that pose poisoning risks without restricting food or medical applications.

Passed Jul 16, 2025 0 co-sponsors
Co-sponsor HR 4396
In committee · Indiana House · Co-sponsor
Uterine Cancer Study Act of 2025

Maddy summaryHR 4396, the Uterine Cancer Study Act of 2025, mandates a study by the Department of Health and Human Services (HHS) into the potential link between chemical hair straighteners and uterine cancer, with a specific focus on higher incidence rates among women of color. The study will review existing research, examine impacts across all racial and ethnic groups, analyze different hair straightener types (including those with dyes or bleach), and assess whether the FDA should require additional safety testing for these products. HHS must submit its study methodology within 45 days of the bill's enactment, begin the study within 180 days, and deliver a final report to Congress within two years. This bill does not create new regulations but directs a specific research effort to gather evidence on a potential health concern. The study directly affects women, particularly women of color, who use hair straightening products and may face elevated uterine cancer risks.

In committee Jul 15, 2025 1 co-sponsor
Co-sponsor HR 4395
In committee · Indiana House · Co-sponsor
Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

Maddy summaryThis bill directs the Department of Health and Human Services to significantly increase federal research funding for uterine fibroids ($30 million annually from 2026-2030), expand coordination of NIH research, and establish a Medicaid data system to track treatment access and costs. It mandates public education on fibroid symptoms, prevalence (especially among Black women, who face higher risk and severity), and non-hysterectomy treatment options. The bill also requires disseminating evidence-based provider resources on managing fibroids while preserving fertility. These provisions directly affect the estimated 26 million U.S. women with fibroids - particularly women of color - and aim to address the current lack of research and treatment data.

In committee Jul 15, 2025 1 co-sponsor
Co-sponsor HR 4392
In committee · Indiana House · Co-sponsor
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Maddy summaryThis bill directs the Health and Human Services Secretary to fund research on early detection and intervention for uterine fibroids, aiming to develop evidence-based approaches for healthcare settings. It authorizes grants to states to support screening (including advanced imaging), patient navigation services, and public education campaigns focused on early detection, with priority given to areas with socially vulnerable populations at higher risk. The bill also funds research into disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. These provisions directly affect women with uterine fibroids, particularly in underserved communities, by expanding access to early detection services and targeted research.

In committee Jul 15, 2025 1 co-sponsor
Showing 191 to 200 of 1,258 bills
Previous 1 … 19 20 21 … 126 Next